Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Acquired by QRG Capital Management Inc.

QRG Capital Management Inc. increased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.3% in the fourth quarter, Holdings Channel reports. The firm owned 5,496 shares of the company’s stock after buying an additional 176 shares during the quarter. QRG Capital Management Inc.’s holdings in Prestige Consumer Healthcare were worth $429,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently bought and sold shares of PBH. Allspring Global Investments Holdings LLC boosted its stake in shares of Prestige Consumer Healthcare by 3.1% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company’s stock worth $126,274,000 after buying an additional 49,331 shares during the period. Geode Capital Management LLC raised its stake in Prestige Consumer Healthcare by 4.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock valued at $95,678,000 after acquiring an additional 50,961 shares during the last quarter. Congress Asset Management Co. lifted its position in Prestige Consumer Healthcare by 5.0% during the 4th quarter. Congress Asset Management Co. now owns 908,742 shares of the company’s stock worth $70,964,000 after acquiring an additional 43,619 shares during the period. Boston Trust Walden Corp grew its stake in shares of Prestige Consumer Healthcare by 43.5% in the 4th quarter. Boston Trust Walden Corp now owns 831,627 shares of the company’s stock valued at $64,942,000 after purchasing an additional 252,089 shares during the last quarter. Finally, Eagle Asset Management Inc. increased its holdings in shares of Prestige Consumer Healthcare by 0.7% in the third quarter. Eagle Asset Management Inc. now owns 434,514 shares of the company’s stock valued at $31,328,000 after purchasing an additional 3,227 shares during the period. 99.95% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Sidoti downgraded Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target for the company. in a report on Monday, December 9th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Canaccord Genuity Group raised their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Finally, Oppenheimer boosted their target price on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research report on Thursday, February 13th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $92.60.

Prestige Consumer Healthcare Stock Up 1.7 %

Shares of NYSE PBH opened at $85.67 on Thursday. The stock has a market capitalization of $4.24 billion, a price-to-earnings ratio of 20.06, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $88.36. The firm has a 50-day moving average price of $80.43 and a 200 day moving average price of $77.57. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.